Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a brief corporate overview followed by a question and answer session at the following two investor conferences during the month of September:

Help employers find you! Check out all the jobs and post your resume.